Picture of bluebird bio logo

BLUE — bluebird bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Bluebird Bio Announces Definitive Agreement To Be Acquired By Carlyle And SK Capital

Feb 21 (Reuters) - bluebird bio Inc  BLUE.O :
    * BLUEBIRD BIO ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED
BY
CARLYLE AND SK CAPITAL
    * BLUEBIRD BIO INC - STOCKHOLDERS TO RECEIVE $3.00 PER SHARE
IN
CASH
    * BLUEBIRD BIO INC - DAVID MEEK EXPECTED TO BECOME CEO OF
BLUEBIRD
UPON CLOSING OF DEAL
    * BLUEBIRD BIO INC - STOCKHOLDERS TO RECEIVE CONTINGENT
VALUE
RIGHT OF $6.84 PER SHARE FROM DEAL
    * BLUEBIRD BIO: ENTERED INTO AMENDMENTS TO LOAN AGREEMENT
WITH
HERCULES CAPITAL TO FACILITATE ADEQUATE LIQUIDITY

Source text:  ID:nBwb7M3fsa 
Further company coverage:  BLUE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on bluebird bio

See all news